MÖMuhammet Engin Özcan

Muhammet Engin Özcan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Muhammet Engin Özcan has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pediatric head and neck necrotizing fasciitis in Somalia: surgical management, VAC utilization, and reconstructive outcomes

    by Adem Küçük, Mohamed Shukri Said, Mohamed Abdullahi, Abdinur Abdullahi Hirsi, Abdishakur Mohamed Abdi, Muhammet Engin Özcan, Çağatay Evrim Afşarlar

  • Open Access

    Diagnostic Performance of Serum Soluble HLA-G for Lung Cancer: A Case–Control Study

    by Muhammet Engin Özcan, Ramazan Memişoğulları, Leyla Yılmaz Aydın

    Objective: Human leukocyte antigen G (HLA-G) is a nonclassical class I molecule with immunosuppressive properties that may facilitate tumor immune escape. Elevated circulating soluble HLA-G (sHLA-G) levels have been reported in several malignancies. This study aimed to evaluate the diagnostic performance of serum sHLA-G levels in patients with lung cancer and to investigate whether smoking status influences these levels.Materials and Methods: This case–control study included 62 patients with newly diagnosed lung cancer, 40 smoker controls, and 31 nonsmoker healthy controls. Serum sHLA-G levels were measured using an enzyme-linked immunosorbent assay (ELISA). Statistical comparisons among groups were performed using one-way analysis of variance and correlation analyses. Receiver operating characteristic (ROC) curve analysis was conducted to assess the diagnostic performance of sHLA-G.Results: Mean serum sHLA-G levels were significantly higher in patients with lung cancer than in nonsmoker controls (16.14 ± 8.71 U/mL vs 10.21 ± 4.77 U/mL, p=0.04). When smoker and nonsmoker controls were combined, the difference remained significant (p

  • Hidden vitamin D insufficiency in a sun-rich equatorial country: age-, sex-, and season-specific evidence from 2961 Somali children

    by Muhammet Engin Özcan, Abdulrahman Nor Abdi, Mustafa Gahnug

    This study aimed to determine the prevalence of vitamin D deficiency and insufficiency, and to evaluate age-, sex-, and season-specific variations in serum 25(OH)D levels among Somali children and adolescents. This retrospective cross-sectional study included pediatric outpatients aged 0–18 years who attended a tertiary care hospital in Mogadishu, Somalia, between January 2020 and August 2025. Serum 25(OH)D levels were analyzed in 2961 participants and categorized as deficient (20 ng/ml) according to Global Consensus Recommendations. Participants were stratified by age group, sex, and season. Statistical analyses were performed using non-parametric tests, with P < .05 considered statistically significant. Mean serum 25(OH)D levels decreased progressively with age, with the highest concentrations observed in infants aged 0–1 year (53.8 ± 18.1 ng/ml) and the lowest in adolescents aged 12–18 years (27.4 ± 13.1 ng/ml). Vitamin D deficiency was absent in infants and rare in children aged 1–6 years, but increased substantially in older age groups, reaching 9.4% deficiency and 23.7% insufficiency among adolescents. Males consistently exhibited higher serum 25(OH)D levels than females across all age groups and seasons (P < .001). Seasonal variation was observed, with the lowest mean levels recorded during July–September. Despite abundant year-round sunlight, vitamin D insufficiency and deficiency are prevalent among Somali children, particularly in adolescents and females. These findings highlight the need for age- and sex-specific public health strategies, including targeted screening and supplementation beyond early childhood, to improve 25(OH)D status in pediatric populations living in sun-rich environments.


  • Open Access

    Hepatitis B, Hepatitis C, and HIV Seroprevalence and Their Association with Dialysis Adequacy and Glycaemic Parameters in Haemodialysis Patients: A Cross-Sectional Study from Somalia

    by Muhammet Engin Özcan, Abdulrahman Nor Abdi, Serpil Doğan

    Background: Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections disproportionately affect haemodialysis (HD) patients in sub-Saharan Africa, yet Somali data remain scarce. We aimed to determine HBsAg, anti-HCV, and anti-HIV seroprevalence among HD patients in Mogadishu and to identify independent predictors of HBsAg seropositivity among measures of dialysis adequacy and glycaemic parameters. Methods: Single-centre retrospective cross-sectional study of 599 HD patients in Mogadishu, Somalia (June 2024–February 2026). Urea reduction ratio (URR) was calculated from pre- and post-dialysis urea. Bivariable comparisons used Mann–Whitney U, Fisher exact, and chi-square tests. Multivariable logistic regression assessed independent predictors of HBsAg positivity, adjusting for age, sex, fasting glucose, URR, and pre-dialysis creatinine (n=569 complete cases). Results: HBsAg positivity was 5.5% (33/599) and anti-HCV 2.3% (14/599); no patient was HIV-positive. HBsAg-positive patients were older, more frequently male, and had higher pre-dialysis urea, creatinine, URR, and fasting glucose (all p< 0.05), with equivalent post-dialysis clearance; HbA1c, AST, and ALT did not differ. Anti-HBs titres were near-absent in HBsAg-positive patients (0.3 vs 26.3 IU/L; p< 0.001). On multivariable analysis, older age (OR 1.023), male sex (OR 2.457), and higher URR (OR 1.031) independently predicted HBsAg positivity (AUROC 0.753); fasting glucose and creatinine were not independent after adjustment. With an events-per-variable ratio of 6.2, these findings are hypothesis-generating. Conclusion: Age, male sex, and URR not glycaemic or hepatic parameters independently predicted HBsAg positivity in this cohort. Near-absent anti-HBs titres indicate a critical vaccination gap, supporting universal hepatitis B screening, high-dose vaccination before dialysis initiation, and enhanced infection control in resource-limited settings.

  • Open Access

    Evaluation of the Relationship Between Disease Severity and Viral Cycle Threshold Value in COVID-19 Patients

    by Arif Dogan Habiloglu, Cihadiye Elif Ozturk, Mehmet Ali Ozel, Serkan Demircan, Burcu Ceren Uludogan, Nagihan Memis, Ozlem Ataoglu, Muhammet Engin Ozcan, Arif Doğan HabiloğluAffiliationsDışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi, İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Kliniği, et al.

    Objective: There is a positive and significant relationship between severity and viral load in some viral diseases. Studies on the relationship between SARS-CoV-2 viral load at diagnosis and severity of coronavirus disease-2019 (COVID-19) have yielded conflicting results. Therefore, we aimed to evaluate the relationship between viral load and the clinical status of patients with COVID-19. Methods: Data of the patients diagnosed with COVID-19 and admitted to our center between May 01 and June 31, 2020, were retrospectively reviewed. The patients were divided into two groups according to their clinical characteristics as mild-moderate and severe. The demographic, laboratory, clinical, and radiological data were retrieved from electronic folders. Results: The entire cohort included 285 patients; 254 had a mild-moderate clinical course, and 31 had a severe course. Statistical analyses revealed that SARS-CoV-2 viral load was not associated with symptom duration and clinical status (p>0.05). According to multivariate logistic regression analysis, only ferritin, C-reactive protein, and lactate dehydrogenase elevations were positively correlated with severe clinical course. (p<0.05). Conclusion: We do not recommend using viral load to predict disease severity in COVID-19. We also found that only ferritin, C-reactive protein, and lactate dehydrogenase accompanied severe clinical course.